AU2069799A - Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation - Google Patents

Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation

Info

Publication number
AU2069799A
AU2069799A AU20697/99A AU2069799A AU2069799A AU 2069799 A AU2069799 A AU 2069799A AU 20697/99 A AU20697/99 A AU 20697/99A AU 2069799 A AU2069799 A AU 2069799A AU 2069799 A AU2069799 A AU 2069799A
Authority
AU
Australia
Prior art keywords
low density
density lipoprotein
viral infections
therapeutic administration
lipoprotein receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20697/99A
Inventor
Patrick Thomas Prendergast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2069799A publication Critical patent/AU2069799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU20697/99A 1998-01-29 1999-01-28 Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation Abandoned AU2069799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7298098P 1998-01-29 1998-01-29
US60072980 1998-01-29
PCT/IB1999/000149 WO1999038524A2 (en) 1998-01-29 1999-01-28 Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation

Publications (1)

Publication Number Publication Date
AU2069799A true AU2069799A (en) 1999-08-16

Family

ID=22110978

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20697/99A Abandoned AU2069799A (en) 1998-01-29 1999-01-28 Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation

Country Status (3)

Country Link
AU (1) AU2069799A (en)
WO (1) WO1999038524A2 (en)
ZA (1) ZA99719B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1111040A1 (en) * 1999-12-10 2001-06-27 Daniel Favre Infection of eukaryotic cells with viruses in vitro
EP1245236A4 (en) * 1999-12-28 2004-09-22 Sumitomo Pharma Preventives and remedies for chronic hepatitis
AU2002243382A1 (en) * 2000-10-25 2002-06-24 Vincent Agnello Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2628082B2 (en) * 1988-12-07 1997-07-09 日東電工株式会社 Immunosuppressants
IL102915A (en) * 1992-01-19 2005-12-18 Yeda Res & Dev Soluble ldl receptor and its preparation
DE4222385A1 (en) * 1992-07-08 1994-01-13 Boehringer Ingelheim Int Isolating substances which inhibit binding of ligands to low-density lipoprotein receptors - comprises incubating LDL receptors with labelled form of ligand in presence of test substance and measuring deg. of binding

Also Published As

Publication number Publication date
WO1999038524A3 (en) 1999-09-23
ZA99719B (en) 1999-10-22
WO1999038524A2 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
AU6406299A (en) Methods and apparatus for improved administration of pharmaceutically active compounds
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
GB2303064B (en) Medicament for nasal administration
PL342988A1 (en) Novel galenic formulations of meloxicam for oral administration
PL328399A1 (en) Drug administration aid
AU3968401A (en) System for warming lower extremities of supine persons
AU2466099A (en) Pharmaceutically active compounds and methods of use thereof
AU5675598A (en) Time-specific controlled release dosage formulations and method of preparing same
AU1403199A (en) Local delivery of therapeutic agents
AU4139801A (en) Controlled delivery of antigens
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
AU1124799A (en) System and method for managing administration of medicine
AU2939897A (en) Administration of histamine for therapeutic purposes
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
AU3471400A (en) Compositions and methods for controlled delivery of virus vectors
AU2069799A (en) Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation
GB9700737D0 (en) Administration of drugs
AU5101798A (en) Method for oral administration of buspirone
ZA9810558B (en) Imidazole derivatives their preparation and their therapeutic application
AU6821196A (en) Transdermal administration of vorozole
AU7482696A (en) Methods for administration of il-12
AU4736797A (en) Non-invasive administration of adeno-associated viral vectors
HK1040610A1 (en) Methods and apparatus for improved administration of pharmaceutically active compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase